ID: ALA3347566

Max Phase: Preclinical

Molecular Formula: C31H31Cl2NO2

Molecular Weight: 520.50

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C=C(C)C[C@H]1[C@H]2c3c(-c4ccc(Cl)c(Cl)c4)cccc3[C@H](CC2(C)C)N1Cc1ccc2c(c1)OCO2

Standard InChI:  InChI=1S/C31H31Cl2NO2/c1-18(2)12-25-30-29-21(20-9-10-23(32)24(33)14-20)6-5-7-22(29)26(15-31(30,3)4)34(25)16-19-8-11-27-28(13-19)36-17-35-27/h5-11,13-14,25-26,30H,1,12,15-17H2,2-4H3/t25-,26-,30-/m0/s1

Standard InChI Key:  IJCLLFSQOMIXGM-JCGRVDTESA-N

Associated Targets(Human)

NOX5 Tchem NADPH oxidase 5 (54 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NOX4 Tchem NADPH oxidase 4 (333 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NOX1 Tchem NADPH oxidase 1 (291 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYBB Tchem Cytochrome b-245 heavy chain (193 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

XDH Xanthine dehydrogenase (2296 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 520.50Molecular Weight (Monoisotopic): 519.1732AlogP: 8.79#Rotatable Bonds: 5
Polar Surface Area: 21.70Molecular Species: BASEHBA: 3HBD: 0
#RO5 Violations: 2HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 9.13CX LogP: 8.46CX LogD: 6.74
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.31Np Likeness Score: 0.06

References

1. Cifuentes-Pagano E, Saha J, Csányi G, Ghouleh IA, Sahoo S, Rodríguez A, Wipf P, Pagano PJ, Skoda EM..  (2013)  Bridged tetrahydroisoquinolines as selective NADPH oxidase 2 (Nox2) inhibitors.,  (7): [PMID:24466406] [10.1039/c3md00061c]
2.  (2014)  Tetrahydroisoquinolines as selective nadph oxidase 2 inhibitors,